BrainsWay Ltd. (BWAY) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

25/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

25
BrainsWay (BWAY) Q2 2026: 42% System Shipment Growth Fuels Platform Expansion and Revenue Visibility
August 12, 2026
25
BrainsWay (BWAY) Q1 2026: RPO Backlog Jumps 25% as Deep TMS Adoption Accelerates
May 13, 2026
25
BrainsWay (BWAY) Q4 2025: Backlog Surges 43% as Recurring Model Drives Revenue Visibility
March 11, 2026
25
BrainsWay (BWAY) Q3 2025: Book-to-Bill Ratio Hits 1.3x, Underscoring Lease-Led Growth Visibility
November 11, 2025
23
BrainsWay (BWAY) Q2 2025: $62M Backlog Anchors Multi-Year Lease Expansion
August 13, 2025
22
BrainsWay (BWAY) Q1 2025: Deep TMS System Shipments Surge 42%, Backlog Nears $60 Million
May 13, 2025
21
BrainsWay (BWAY) Q4 2024: 27% Revenue Growth Anchored by Enterprise Expansion and Clinical Innovation
March 11, 2025
BrainsWay (BWAY) Q2 2024: 28% Revenue Growth Propels Deep TMS Install Base Past 1,200
August 06, 2024
BrainsWay (BWAY) Q1 2024: 37% Revenue Surge Signals Enterprise TMS Adoption Shift
May 08, 2024
BrainsWay (BWAY) Q4 2023: 50% Revenue Surge Anchors Breakout Profitability and International Expansion
March 06, 2024

Browse all companies